Helicobacter pylori infection and dementia: Can actual data reinforce the hypothesis of a causal association?

Panminerva Medica

Volumn 56, Issue 3, 2014, Pages 195-199

  Adriani, A ^a   Fagoonee, S ^b   De Angelis, C ^a   Altruda, F ^b   Pellicano, R ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Alzheimer disease; Dementia; Helicobacter pylori

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; CASE CONTROL STUDY; COMPLICATION; COST BENEFIT ANALYSIS; DEMENTIA; DISEASE COURSE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LONGITUDINAL STUDY; MALE; MICROBIOLOGY; PATHOPHYSIOLOGY;

AGE FACTORS; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 84927171029     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604.
2. Malfertheiner P, Megraud F, O'Morain C, Atherton J, Axon AT, Bazzoli F et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
3. Adriani A, Astegiano M, Smedile A, Rizzetto M, Pellicano R. Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study. Minerva Med 2013;104:495-6.
4. Fagoonee S, Astegiano M, Smedile A, Pellicano R. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study. Panminerva Med 2013;55:309-10.
5. Marietti M, Gasbarrini A, Saracco G, Pellicano R. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art. Panminerva Med 2013;55:277-81.
6. Roubaud-Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter 2013;18(SUPPL. 1):44-51.
7. Göthe F, Enache D, Wahlund LO, Winblad B, Crisby M, Lökk J et al. Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment. Panminerva Med 2012;54:161-70.
8. Annweiler C, Montero-Odasso M. Vascular burden as a substrate for higher-level gait disorders in older adults. A review of brain mapping literature. Panminerva Med 2012;54:189-204.
9. Sierra C. Cerebral small vessel disease, cognitive impairment and vascular dementia. Panminerva Med 2012;54:179-88.
10. De La Monte SM. Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases. Panminerva Med 2012;54:171-8.
11. Kalaria RN. Risk factors and neurodegenerative mechanisms in stroke related dementia. Panminerva Med 2012;54:139-48.
12. Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med 2012;103:73-96.
13. Munno D, Sterpone S, Fania S, Cappellin F, Mengozzi G, Saroldi M et al. Plasma brain derived neurotrophic factor levels and neuropsy-chological aspects of depressed patients treated eith paroxetine. Panminerva Med 2013;55:377-84.
14. Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 2003;34:2126-2131.
15. Itzhaki RF, Dobson CB, Shipley SJ, Wozniak MA. The role of viruses and of APOE in dementia. Ann NY Acad Sci 2004;1019:15-18.
16. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis 2002;9:82-87.
17. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998;187:23-42.
18. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009;5:348-360.
19. Strandberg TE, Pitkala KH, Linnavuori K, Tilvis RS. Cognitive impairment and infectious burden in the elderly. Arch Gerontol Geriatr Suppl 2004;9:419-423.
20. Aiello AE, Haan MN, Pierce CM, Simanek AM, Liang J. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 2008;63:610-618.
21. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 2006;54:1046-1054.
22. Bilbo SD. Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol Learn Mem 2010;94:57-64.
23. Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol 2007;14:976-982.
24. Letenneur L, Peres K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 2008;3(11):e3637.
25. Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology 2013;80:1209-15.
26. Berrutti M, Pellicano R, Fagoonee S, Saracco G, Rizzetto M. Helicobacter pylori and dementia. Which consistency for an association? Panminerva Med 2007;49:227-30.
27. Roubaud-Baudron C, Letenneur L, Langlais A, Buissonniere A, Megraud F, Dartigues JF et al. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agees QUID Study. J Am Geriatr Soc 2013;61:74-8.
28. Chang Y-P, Chiu G-F, Kuo F-C, Lai C-L, Yang Y-H, Hu H-M et al. Eradication of Helicobacter pylori is associated with the progression of dementia: a population-based study. Gastroenterol Res Pract 2013;2013:175729.
29. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
30. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med. 2004;15:381-6.
31. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006;66:938-40.
32. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 2009;119:765-77.
33. Shiota S, Murakami K, Yoshiiwa A, Yamamoto K, Ohno S, Kuroda A et al. The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol 2011;258:1460-3.
34. Kountouras J, Zavos C, Boziki M, Gavalas E, Kyriakou P, Deretzi G. Association between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol 2011;258:2086.
35. Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, Megraud F, Salles N. Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging 2012;33:1009e1011-09.
36. Hill B.A. The environment and disease: association or causation. Proc R Soc Med 1965;58:295-300.
37. Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol 2009;256:758-67.
38. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 2010;23:199-204.
39. Kountouras J, Boziki M, Zavos C, Gavalas E, Giartza-Taxidou E, Venizelos I et al. A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathobiology and course. Neurobiol Aging 2012;33:e3-4.
40. Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D, Kapetanakis N et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses 2007;68:378-88.
41. Kountouras J, Gavalas E, Boziki M, Zavos C. Helicobacter pylori may be involved in cognitive impairment and dementia development through induction of atrophic gastritis, vitamin B-12 folate deficiency, and hyperhomocysteinemia sequence. Am J Clin Nutr 2007;86:805-6.
42. Ge R, Sun X. The in vivo functions of a histidine-rich protein Hpn in Helicobacter pylori: linking gastric and Alzheimer's diseases together? Med Hypotheses 2011;77:788-90.
43. Salles N, Letenneur L, Buissonnière A, Jehanno A, Dartigues JF, Mégraud F. Does Helicobacter pylori affect life expectancy? J Am Geriatr Soc 2010;58:1607-9.
44. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
45. Larsson PT, Hallerstam S, Rosfors S, Wallen NH. Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol 2005;24:43-51.
46. Fagoonee S, De Angelis C, Elia C, Silvano S, Oliaro E, Rizzetto M et al. Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med 2010;101:121-5.
47. Schulz JD, Hawkes EL, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses 2006;66:1222-6.